In conclusion, the presented data helped us understand and summarize the dysregulation caused by CBS deficiency in HCU and how this dysregulated system is affected by Met restriction, a current cornerstone therapy for pyridoxine non-responsive HCU. Here, CBS is linked to hyperinsulinemic hypoglycemia, familial, 4.